View drug registration information details.
Items | Registration information |
ID | 248 |
No | 248 |
Brand Name | POMMADX |
Ingredients | POMALIDOMIDE 2 MG |
Dosage Form | CAPSULE |
Primary Packaging | BOTTLE |
Storage | STORE BELOW 30 C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 21 TABLET'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTINEOPLASTIC |
Indications | USED IN COMBINATION WITH DEAMETHASONE TO TREAT MULTIPLE MYELOMA (A TYPE OF CANCER OF THE BONE MARROW) THAT HAS NOT IMPROVED DURING OR WITHIN 60 DAYS OF TREATMENT WITH AT LEAST TWO OTHER MEDICATIONS INCLUDING LENALIDOMIDE AND PROTEASOME INHIBITOR. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
No |
Description | BLUE CAPSULE |
Note | |
License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 10 L 1022/23 |
FDD Registration Date | 2023-10-10 |
Expiry Date | 2026-10-09 |
Back to drug list
|